Ultima System (UL-800);Ultimate Face Package (UL-800-Face-Set);Ultimate Shape Extension Kit 1 (UL-800-Shape-Ext-Kit-1);Ultimate Shape Extension Kit 2 (UL-800-Shape-Ext-Kit-2)
Fit-Pro KFT (Ltd.) - DBA E-Fit · Decision date Sep 27, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 27, 2026 for K260945, a traditional 510(k) submitted March 23, 2026 by Fit-Pro KFT (Ltd.) - DBA E-Fit of Budapest, Hungary, with Medical Device Academy, Inc. as correspondent. The submission covers the Ultima System (UL-800) and three accessory packages: Ultimate Face Package (UL-800-Face-Set) and Ultimate Shape Extension Kits 1 and 2. The review panel was Physical Medicine, and the primary product code listed in the source record is NGX; the FDA letter also cites NFO and ILY.
The FDA letter describes two energy modalities, electrical stimulation and light output, operated separately and not delivered simultaneously. The NGX function is described for muscle conditioning of healthy muscles, and the NFO facial mode for aesthetic stimulation of labeled forehead and cheek sites on intact skin; the letter states neither is intended for rehabilitation or treatment of medical conditions. The letter lists K202148 and K242532 as predicates for the electrical stimulation comparison and K212275 and K15133 for the photostimulation comparison. SESE is a clearance, not a PMA approval. The source does not include the indications enclosure or performance data, so clinical support for the clearance is not established here.
The source does not state whether the accessory kits carry separate indications or limitations, and the listed product codes beyond NGX are not reconciled with the structured record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 27, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260945
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Fit-Pro KFT (Ltd.) - DBA E-Fit
- Product code
- NGX
- Decision code
- SESE
- Decision date
- Sep 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Muscle, Powered, For Muscle Conditioning.
- Applicant
- Fit-Pro KFT (Ltd.) - DBA E-Fit
- Product code
- NGX
- FDA device class
- 2
FDA decision timeline
K260945 received
Application receipt date recorded by FDA.
K260945 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NGX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Changsha Anxiang Medical Technology Co., Ltd. | 510(k) clearance | Oct 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Fit-Pro KFT (Ltd.) - DBA E-Fit
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Budapest
Sources and methodology
- Original FDA record: K260945
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records